Skip to main content Scroll Top

ACTUS MOD

Ropular Posts
Clear Filters
Neuroprotective effect of a new photobiomodulation technique against Aβ25-35 peptide-induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer’s disease suggested
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
Designing a unique treatment protocol by assessing efficient photonic and magnetic emission parameters on an Alzheimer’s disease animal model
Clear Filters
ESCC 2026 – Nice | 10-12 June
AAIC 2026 – London | 12-15 July
REGEnLIFE: a new step towards a practical and accessible treatment to address the public health challenges posed by Alzheimer’s disease.
Research. Regenlife is testing its technologies for Alzheimer’s disease at Biofortis in Nantes
Regenlife opens a clinical research centre at Biofortis in Nantes to study Alzheimer’s disease